Tesaro’s Zejula primed for EU approval, battle with AZ
September 18, 2017EU regulators recommend PARP inhibitor Zejula
cancer
Roche cancer blockbusters face competition in US and EU
September 18, 2017
ESMO 2017 round up: BMS and AZ bounce back
September 12, 2017
Roche under pressure as second rituximab biosimilar filed in US
September 12, 2017Sandoz is following closely behind rival from Teva and Celltrion.
Roche hopes blood test will predict immunotherapy efficacy
September 8, 2017Test could help determine which patients respond to immunotherapies.
FDA puts hold on AZ and Celgene immunotherapy trials
September 8, 2017Regulator is exploring safety of immunotherapy combinations in blood cancer
FDA halts recruitment to three BMS Opdivo trials
September 7, 2017FDA is investigating safety of immunotherapies in blood cancer.
Janssen art campaign raises awareness about blood cancer
September 5, 2017
